The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3.0 million before deducting the placement agent’s fees and other estimated offering expenses ...
Columnist Rick Newman says voters thought Trump would be better for the economy, but they're starting to worry about his tariffs. Details of any open derivative or option positions, or agreements to ...
(TSXV: MGRO) has completed the previously announced acquisition of NexusBioAg from Univar Solutions Canada. Classified as an asset purchase agreement, the arrangement saw ...
The aggregate gross proceeds to the Company from the offering are expected to be approximately $20.3 million, before deducting offering expenses payable by the Company. The Company intends to use the ...
FibroBiologics, Inc. (Nasdaq: FBLG) announced the successful closure of the second $5 million tranche of financing as part of its Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., an ...
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Investors with ownership limitations of 4.99% have opted for this investment structure. The Securities Purchase Agreement and form of Pre-Funded Warrants are detailed in Exhibits 10.1 and 4.1 of the ...
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).